MR-Guided Radiotherapy for Rectal Cancer: Current Perspective on Organ Preservation.
MR-linac
MRI
dose escalation
radiotherapy
rectal cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
21
10
2020
accepted:
08
02
2021
entrez:
16
4
2021
pubmed:
17
4
2021
medline:
17
4
2021
Statut:
epublish
Résumé
Online MRI-guided radiotherapy (MRgRT) is one of the most recent technological advances in radiotherapy. MRgRT permits the visualization of tumorous and healthy tissue while the patient is on the treatment table and online daily plan adaptations following the observed anatomical changes. In the context of rectal cancer, online MRgRT is a very promising modality due to the pronounced geographical variability of tumor tissues and the surrounding healthy tissues. This current paper will discuss the possible applications of online MRgRT, in particular, in terms of radiotherapy dose escalation and response prediction in organ preservation approaches for rectal cancer.
Identifiants
pubmed: 33859937
doi: 10.3389/fonc.2021.619852
pmc: PMC8042309
doi:
Types de publication
Journal Article
Langues
eng
Pagination
619852Informations de copyright
Copyright © 2021 Boldrini, Intven, Bassetti, Valentini and Gani.
Déclaration de conflit d'intérêts
LB has active research agreements with ViewRay Inc and has received speaker honoraria for scientific presentations. CG: University Hospital Tübingen receives financial and technical support, including costs for travels (CG) and symposia from Elekta AB (Stockholm, Sweden), under a research agreement. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Transl Radiat Oncol. 2019 Apr 12;18:80-86
pubmed: 31341981
J Clin Oncol. 2016 Nov 1;34(31):3773-3780
pubmed: 27432930
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):782-90
pubmed: 19289265
Magn Reson Imaging Clin N Am. 2020 Feb;28(1):105-115
pubmed: 31753230
Acta Oncol. 2008;47(7):1317-24
pubmed: 18661433
Radiother Oncol. 2021 Jan;154:172-178
pubmed: 32976875
Med Phys. 2018 Oct;45(10):4345-4354
pubmed: 30129043
Lancet Oncol. 2015 Aug;16(8):957-66
pubmed: 26187751
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):74-80
pubmed: 22763027
J Clin Oncol. 2012 Jun 1;30(16):1926-33
pubmed: 22529255
Radiother Oncol. 2014 Nov;113(2):158-65
pubmed: 25483833
Clin Transl Radiat Oncol. 2020 Dec 03;26:86-91
pubmed: 33336086
Radiother Oncol. 2009 Aug;92(2):202-9
pubmed: 19454365
Clin Transl Radiat Oncol. 2019 Apr 08;18:66-67
pubmed: 31341978
Front Oncol. 2019 May 10;9:318
pubmed: 31134146
Phys Imaging Radiat Oncol. 2020 Oct 17;16:69-73
pubmed: 33458346
Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1008-1018
pubmed: 32565319
Acta Oncol. 2018 Jun;57(6):723-727
pubmed: 29157069
Radiother Oncol. 2014 Oct;113(1):1-9
pubmed: 25281582
Lancet Oncol. 2012 Jul;13(7):679-87
pubmed: 22627104
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):67-72
pubmed: 23790770
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):863-70
pubmed: 21398048
Visc Med. 2019 Apr;35(2):119-123
pubmed: 31192245
Clin Transl Radiat Oncol. 2019 Apr 08;18:98-101
pubmed: 31341983
J Clin Oncol. 2011 Dec 10;29(35):4633-40
pubmed: 22067400
Br J Radiol. 2017 Mar;90(1071):20160739
pubmed: 28079398
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1347-1356
pubmed: 32758641
Radiol Med. 2019 Feb;124(2):145-153
pubmed: 30374650
Clin Transl Radiat Oncol. 2019 Apr 17;18:102-103
pubmed: 31341984
Clin Transl Radiat Oncol. 2017 Mar 23;3:9-15
pubmed: 29658007
Trials. 2015 Feb 22;16:58
pubmed: 25888548
Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1514-1532
pubmed: 30125635
Radiother Oncol. 2019 May;134:110-118
pubmed: 31005204
Clin Transl Radiat Oncol. 2019 Apr 02;18:54-59
pubmed: 31341976
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):97-102
pubmed: 21481722
Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40
pubmed: 28881920